Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00328614 2025-05-16

Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer

Phase 1 Completed

32 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Phase 1 Completed

20 enrolled

Genitourinary

Prostatic Neoplasms

NCT02603965 2025-05-02

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Phase 1 Completed

25 enrolled

Genitourinary

Prostatic Neoplasms

NCT02339168 2025-05-01

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Phase 1 Completed

25 enrolled

Genitourinary

Prostatic Neoplasms

NCT05940298 2025-04-09

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8

Phase 1 Completed

10 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06101927 2025-04-09

Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

Phase 1 Completed

10 enrolled

Genitourinary

Prostatic Neoplasms

NCT06641219 2025-04-09

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Phase 1 Completed

7 enrolled

Genitourinary

Prostatic Neoplasms

NCT06559007 2025-03-18

Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants

Phase 1 Completed

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT05332340 2025-03-07

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Phase 1 Completed

12 enrolled 10 charts

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT04428203 2025-03-05

Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

Phase 1 Completed

21 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT01792687 2025-03-04

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Phase 1 Completed

6 enrolled

Genitourinary

Prostatic Neoplasms

NCT05441501 2025-03-04

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Phase 1 Completed

39 enrolled

Genitourinary

Prostatic Neoplasms

NCT03073395 2025-02-26

Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

Phase 1 Completed

30 enrolled

Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

NCT03805594 2025-02-25

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

43 enrolled 20 charts

Genitourinary

Prostatic Neoplasms

NCT03436745 2025-02-11

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Phase 1 Completed

12 enrolled 11 charts

Genitourinary

Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT01638533 2025-02-07

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Phase 1 Completed

37 enrolled

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryHead & NeckLymphoidNETOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Glioma, Lung Neoplasms, Lymphoma, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Neuroendocrine Tumors, Hematologic Neoplasms

NCT02182219 2025-01-22

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

Phase 1 Completed

21 enrolled

Genitourinary

Prostatic Neoplasms

NCT00739453 2024-11-20

A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Phase 1 Completed

95 enrolled

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04094519 2024-11-20

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

Phase 1 Completed

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT02009449 2024-11-15

IVY

Phase 1 Completed

353 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02635672 2024-11-15

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Phase 1 Completed

110 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06566989 2024-10-23

MK-5684-008

Phase 1 Completed

8 enrolled

Genitourinary

Prostatic Neoplasms

NCT06554639 2024-10-15

MK-5684-011

Phase 1 Completed

12 enrolled

Genitourinary

Prostatic Neoplasms

NCT02555397 2024-10-10

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Phase 1 Completed

15 enrolled 11 charts

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT05410002 2024-10-03

Diet Effect on Cancer Treatment Outcome

Phase 1 Completed

160 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms

NCT04672460 2024-09-25

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Phase 1 Completed

73 enrolled 18 charts

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03558711 2024-09-19

NGP1

Phase 1 Completed

6 enrolled

Genitourinary

Prostatic Neoplasms

NCT02566772 2024-09-03

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

Phase 1 Completed

130 enrolled

Genitourinary

Prostatic Neoplasms

NCT04701021 2024-07-08

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Phase 1 Completed

12 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT03276572 2024-06-13

Phase I Trial of 225Ac-J591 in Patients With mCRPC

Phase 1 Completed

32 enrolled 19 charts

Genitourinary

Prostatic Neoplasms

NCT02184533 2024-05-28

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Phase 1 Completed

15 enrolled

GenitourinaryPlasma cell

Multiple Myeloma, Plasmacytoma, Prostatic Neoplasms

NCT03177460 2024-05-03

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Phase 1 Completed

33 enrolled

Genitourinary

Prostatic Neoplasms

NCT04086966 2024-04-26

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Phase 1 Completed

10 enrolled 7 charts

Genitourinary

Prostatic Neoplasms

NCT03822871 2024-03-21

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Phase 1 Completed

17 enrolled 18 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

MK-5684-001

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

REDEX

A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

OncoACP-3

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

PROQURE-1

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8

Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

IVY

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

MK-5684-008

MK-5684-011

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Diet Effect on Cancer Treatment Outcome

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

NGP1

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Phase I Trial of 225Ac-J591 in Patients With mCRPC

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer